Profiel
Gary Allenby is the founder and current Chief Executive Officer of Aurelia Bioscience Ltd, which was founded in 2003.
Actieve functies van Gary Allenby
| Bedrijven | Functie | Begin |
|---|---|---|
Aurelia Bioscience Ltd.
 Aurelia Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Aurelia Bioscience Ltd. operates as pre-clinical contract Research Company which engages in biochemical and call based compound screening. The firm specializes in bioassay development, high throughput screening of compounds, label free phenotypic bio screening, FLIPR, FMAT, Envision, Enspire technology, Drug screening instrument and reagents consultancy. The company was founded by Gary Allenby, Kathy Dodgson and Kevin Hart in 2003 and is headquartered in Nottingham, the United Kingdom. | Algemeen Directeur | 01-01-2003 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Aurelia Bioscience Ltd.
Aurelia Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Aurelia Bioscience Ltd. operates as pre-clinical contract Research Company which engages in biochemical and call based compound screening. The firm specializes in bioassay development, high throughput screening of compounds, label free phenotypic bio screening, FLIPR, FMAT, Envision, Enspire technology, Drug screening instrument and reagents consultancy. The company was founded by Gary Allenby, Kathy Dodgson and Kevin Hart in 2003 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
